옵션 체인은 다양한 행사가격과 만기일에 대한 BloomZ의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 BloomZ에 대한 시장 심리를 평가합니다..

BloomZ (NASDAQ:BLMZ) 주식, 옵션 체인

BloomZ Inc operates as an audio-producing and voice actor managing company. The company provides audio production services and voice-acting educational services in Japan. The business lines of the company are the audio production business, the VTuber management business, and the voice actor workshop business. The audio production comprises producing audios for animations and video games using dubbing, BGM producing, and mixing techniques; the Vtuber management business creates motion-capture technology for streamers to provide the voice to stream real-time videos featuring human facial expressions and gestures; and the voice actor workshop provides practical voice acting services.

BloomZ Inc

News

QNTM

Quantum Biopharma Licensee Celly Nutrition Changes Name To Unbuzzd Wellness Inc. Effective May 23, 2025

DA Davidson analyst Tom White upgrades eXp World Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPI#NASDAQ">EXPI</a>) from Neutral to Buy and announces $10.75 price target.

Upgrades

Price Target

Analyst Ratings

EXPI

DA Davidson Upgrades eXp World Holdings to Buy, Announces $10.75 Price Target

Quantum BioPharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#NASDAQ">QNTM</a>) (CSE:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#CSE">QNTM</a>) (FRA: 0K91) ("Quantum BioPharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that Unbuzzd Wellness Inc. (formerly, Celly Nutrition Corp.) (the "Company"), the company behind unbuzzdTM, the scientifically-proven beverage that accelerates alcohol metabolism, restores mental clarity and reduces hangover symptoms, that it has hired leading audit firm MNP LLP ("MNP") effective May 20, 2025, to conduct Public Company Accounting Oversight Board ("PCAOB") audits of the Company's financial statements in preparation for a possible initial public offering ("IPO"). The Company's predecessor auditor, Stern &amp; Lovrics LLP (the "Predecessor Auditor") resigned effective May 20, 2025, at the Company's request, and the Company's board of directors, upon the audit committee's recommendation, appointed MNP to fill the resulting vacancy until the close of the next annual meeting of the Company's shareholders.

CSE:QNTM

Quantum BioPharma's Unbuzzd Wellness Inc. Engages MNP for PCAOB Audits Ahead Of Potential IPO, Replacing Stern & Lovrics

Chardan Capital analyst Geulah Livshits maintains Taysha Gene Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSHA#NASDAQ">TSHA</a>) with a Buy and raises the price target from $7 to $9.

TSHA

Chardan Capital Maintains Buy on Taysha Gene Therapies, Raises Price Target to $9

Raymond James analyst Srini Pajjuri maintains Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) with a Outperform and lowers the price target from $130 to $110.

MRVL

Raymond James Maintains Outperform on Marvell Tech, Lowers Price Target to $110

Barrington Research analyst Vincent Colicchio maintains Alithya Group (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ALYA#TSX">ALYA</a>) with a Outperform and maintains C$2.5 price target.

TSX:ALYA

Barrington Research Maintains Outperform on Alithya Group, Maintains C$2.5 Price Target

Earnings

CORRECTION: Aurora Mobile Q1 Adj. EPADS $(0.06) Down From $(0.04) YoY, Sales $12.26M Up From $8.94M YoY

JetBlue (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) and United (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) today announced Blue Sky: a new and unique collaboration that gives customers of both airlines even more options to find flights that fit their plans as well as new opportunities to earn and use MileagePlus&#xAE; miles and TrueBlue points across both airlines.

JBLU

JetBlue and United Team Up to Expand Flight Options and Shared Rewards

Guidance

ALAR

Alarum Technologies Sees Q2 Sales $7.663M-$8.137M vs $8.35M Est

WIIM

TSLA

Tesla shares are trading higher after CEO Elon Musk announced his role as Special Government Employee has concluded.

BOSC

BOS CEO Says 'Based on our first quarter performance and contracted backlog, we are optimistic about surpassing our full-year outlook for 2025, which are revenues of $44 million and net income of $2.5 million,'

HC Wainwright &amp; Co. analyst Matthew Caufield reiterates DiaMedica Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DMAC#NASDAQ">DMAC</a>) with a Buy and maintains $10 price target.

Reiteration

DMAC

HC Wainwright & Co. Reiterates Buy on DiaMedica Therapeutics, Maintains $10 Price Target

Earnings Misses

Alarum Technologies Q1 Adj. EPADS $0.16, Inline, Sales $7.13M Miss $7.87M Estimate

BOS Better Online Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOSC#NASDAQ">BOSC</a>) reported quarterly earnings of $0.23 per share. This is a 76.92 percent increase over earnings of $0.13 per share from the same period last year. The company reported $15.03 million in sales this quarter. This is a 33.13 percent increase over sales of $11.29 million the same period last year.

BOS Better Online Solns Q1 EPS $0.23 Up From $0.13 YoY, Sales $15.03M Up From $11.29M YoY

Telsey Advisory Group analyst Dana Telsey maintains Abercrombie &amp; Fitch (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANF#NYSE">ANF</a>) with a Outperform and maintains $125 price target.

Telsey Advisory Group Maintains Outperform on Abercrombie & Fitch, Maintains $125 Price Target

Incannex Healthcare Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IXHL#NASDAQ">IXHL</a>), a clinical-stage pharmaceutical company developing novel combination therapies, today announced that the Phase 3 component of the RePOSA clinical trial will proceed. The U.S. Food and Drug Administration (FDA) previously reviewed and authorized the protocol to proceed under the Company's Investigational New Drug (IND) application. The study will evaluate the efficacy and safety of&nbsp;IHL-42X, Incannex's lead asset for the treatment of&nbsp;obstructive sleep apnea (OSA)—a condition affecting an estimated one billion people globally with no approved oral pharmaceutical therapy.
With the FDA authorization in place, Incannex will initiate&nbsp;Phase 3 immediately&nbsp;following the completion of Phase 2, leveraging a shared protocol and U.S. based infrastructure to maximize efficiency and speed.

IXHL

Incannex Healthcare To Proceed Phase 3 Component Of RePOSA Clinical Trial Following FDA Authorization

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Photronics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAB#NASDAQ">PLAB</a>)</h3>
<ul class="wp-block-list">
<li>On May 28, Photronics reported worse-than-expected second-quarter financial results and issued third-quarter guidance below estimates.. The company's stock fell around 16% over the past five days and has a 52-week low of $16.46.</li>
<li>RSI Value: 22.5</li>
<li>PLAB Price Action: Shares of Photronics fell 15.6% to close at $16.94 on Wednesday.</li>
<li>Edge Stock Ratings: 15.98 Momentum score with Value at 93.15. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/PLAB"><img loading="lazy" decoding="async" width="492" height="178" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072656/image-378.png" alt="" class="wp-image-931348" style="width:357px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072656/image-378.png 492w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072656/image-378-300x109.png 300w" sizes="(max-width: 492px) 100vw, 492px" /></a></figure>
<h3 class="wp-block-heading">Okta Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On May 27, Okta reported first-quarter revenue of $688 million, beating analyst estimates of $680.25 million. The company reported adjusted earnings of 86 cents per share, beating analyst estimates of 77 cents per share. "Okta had a solid start to FY26 highlighted by record operating profit and another quarter of robust free cash flow. The world's biggest organizations continue to turn to Okta to solve identity security across their workforces, customers, and AI use cases," said Todd McKinnon, co-founder and CEO of Okta. The company's stock fell around 15% over the past five days and <a href="https://www.benzinga.com/quote/OKTA">has a 52-week low</a> of $70.56.</li>
<li>RSI Value: 25.2</li>
<li>OKTA Price Action: Shares of Okta fell 16.2% to close at $105.22 on Wednesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0529">OKTA stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0529"><img loading="lazy" decoding="async" width="915" height="830" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072758/image-379.png" alt="" class="wp-image-931352" style="width:641px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072758/image-379.png 915w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072758/image-379-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072758/image-379-768x697.png 768w" sizes="(max-width: 915px) 100vw, 915px" /></a></figure>
<h3 class="wp-block-heading">Cloudastructure Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>)</h3>
<ul class="wp-block-list">
<li>On May 15, Cloudastructure reported that for the quarter ending March 31, revenue soared 212% year-over-year. &#8220;Cloudastructure began 2025 with substantial momentum,&#8221; said James McCormick, Chief Executive Officer of Cloudastructure. &#8220;Revenue for the quarter more than tripled year-over-year, we turned the corner on gross profit, and we secured the largest contract in our Company&#8217;s history. The demand for real time crime deterrence has never been stronger—and we are leading the charge.&#8221; The company's stock fell around 43% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/CSAI">low of $2.68.</a></li>
<li>RSI Value: 28.8</li>
<li>CSAI Ltd Price Action: Shares of Cloudastructure dipped 7.1% to close at $2.74 on Wednesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0529">CSAI shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0529"><img loading="lazy" decoding="async" width="892" height="825" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072923/image-380.png" alt="" class="wp-image-931357" style="width:597px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072923/image-380.png 892w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072923/image-380-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29072923/image-380-768x710.png 768w" sizes="(max-width: 892px) 100vw, 892px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45641430/jim-cramer-says-this-quantum-computing-stock-is-so-high-and-too-speculative">Jim Cramer Says This Quantum Computing Stock Is &#8216;So High&#8217; And &#8216;Too Speculative&#8217;</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

CSAI

OKTA

PLAB

Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter

NOVA

Sunnova shares are trading lower after Bloomberg reported the Trump administration canceled a $3 billion loan to the company.

Telsey Advisory Group analyst Dana Telsey maintains Macy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/M#NYSE">M</a>) with a Market Perform and lowers the price target from $15 to $14.

Telsey Advisory Group Maintains Market Perform on Macy's, Lowers Price Target to $14

e.l.f. Beauty shares are trading higher after the company reported better-than-expected quarterly results and announced it will acquire Rhode.

Press Releases

BloomZ Completes Audio Production Animation Projects

BloomZ to Manage Sound Production for the Upcoming Anime Adaptation "Dark Machine"

BloomZ Partners with Badge Inc. to Revolutionize Fan Club Management

BloomZ Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

BloomZ Announces Strategic Business Alliance with Foom Co. Ltd. to Expand into the Webtoon Industry

BloomZ Announces Business Alliance with TechnoBlood eSports Co., Ltd. to Integrate VTubers into the E-Sports Domain

BloomZ Reports Fiscal Year 2024 Financial and Operational Results

BloomZ Inc. Regains Compliance with Nasdaq Continued Listing Standards

BloomZ Inc. Appoints Ryoshin Nakade as Co-Chief Executive Officer and Co-Chairman of the Board

BloomZ Announces Business Alliance with M-NEXT Holdings Co., Ltd. to Drive Affiliated Talent Growth and Fuel Store Foot Traffic

BLMZ

Anghami

BloomZ

Brera Holdings PLC - Class B Ordinary Shares

Brera Holdings

Pop Culture Group Co., Ltd - Class A Ordinary Shares

Pop Culture Gr

Dolphin Entertainment, Inc. - Common Stock

Dolphin Entertainment

Kuke Music Holding Limited American Depositary Shares (each representing ten (10) Class A Ordinary Shares)

Comments

BloomZ

BloomZ (BLMZ) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌